News
FDA’s New Priority Voucher Program for Drug Developers Ties Incentives to Defined National Interests
The US Food and Drug Administration recently announced the launch of a regulatory incentive program pilot program, the ...
A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with ...
MAXONA Pharmaceuticals today announced that the company has submitted an Investigational New Drug (IND) Application to the ...
2d
Tech Xplore on MSNA new AI tool designs medical drugs and tells scientists how to make them
Researchers from Simon Fraser University have unveiled an artificial intelligence framework that could transform drug ...
The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many ...
The US Food and Drug Administration (FDA) recently announced the availability of the first-ever centralized database of Complete Response ...
The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...
Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...
“All we can do now is give them trazodone two hours before a storm and try to comfort them,” Cantwell said. Anti-anxiety ...
The new guidelines aim to streamline India’s drug approvals, improve transparency, and align regulatory practices with global ...
Everest Medicines (HKEX 1952.HK, 'Everest') today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New Drug Application ...
The agency’s new program is designed to increase regulatory predictability and streamline review of domestic manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results